Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
203
-
Total 13F shares, excl. options
-
86.5M
-
Shares change
-
-1.22M
-
Total reported value, excl. options
-
$1.42B
-
Value change
-
-$23.3M
-
Put/Call ratio
-
1.1
-
Number of buys
-
113
-
Number of sells
-
-92
-
Price
-
$16.45
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q1 2018
249 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q1 2018.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 203 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 86.5M shares
of 106M outstanding shares and own 81.73% of the company stock.
Largest 10 shareholders include BlackRock Inc. (12.9M shares), FEDERATED INVESTORS INC /PA/ (12.7M shares), VANGUARD GROUP INC (8.75M shares), INGALLS & SNYDER LLC (6.82M shares), Consonance Capital Management LP (5.19M shares), RENAISSANCE TECHNOLOGIES LLC (4.8M shares), ACADIAN ASSET MANAGEMENT LLC (3.31M shares), STATE STREET CORP (3.14M shares), DIMENSIONAL FUND ADVISORS LP (1.58M shares), and Invesco Ltd. (1.54M shares).
This table shows the top 203 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.